[
    [
        {
            "time": "",
            "original_text": "股指叠创新低 独角兽新股加速价值回归",
            "features": {
                "keywords": [
                    "股指",
                    "新低",
                    "独角兽",
                    "新股",
                    "价值回归"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股指叠创新低 独角兽新股加速价值回归",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[看好评级] 医药行业2018年中期投资策略：医药一枝独秀上半年全面牛 短暂调整后下半年看结构牛行情",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "全面牛",
                    "结构牛",
                    "短暂调整"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级] 医药行业2018年中期投资策略：医药一枝独秀上半年全面牛 短暂调整后下半年看结构牛行情",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "国内首个CAR-T临床申请获批 千亿美元市场将开启(股)",
            "features": {
                "keywords": [
                    "CAR-T",
                    "临床申请",
                    "获批",
                    "千亿美元市场"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内首个CAR-T临床申请获批 千亿美元市场将开启(股)",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]